Floatz logo

MELATONIN

Strokes Thrombotic

Hospital San Carlos, MadridSmall moleculePhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Strokes Thrombotic cohort.

Asset / SponsorPhaseRating
mlc1501
Moleac Pte Ltd.
Phase 2/3BB
WARFARIN
Wuhan Asia Heart Hospital
D
DABIGATRAN ETEXILATE
Wuhan Asia Heart Hospital
D

Same molecule, other indications

MELATONIN is also rated in:

traumatic brain injuryDormant
BBB
Indicative ·
74 / 100
View asset →
bipolar disorderDormant
BBB
Indicative ·
72 / 100
View asset →
circadian rhythm sleep disorderDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →